375 related articles for article (PubMed ID: 23423362)
1. Role of cerebral cortex in the neuropathology of Huntington's disease.
Estrada-Sánchez AM; Rebec GV
Front Neural Circuits; 2013; 7():19. PubMed ID: 23423362
[TBL] [Abstract][Full Text] [Related]
2. Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.
Estrada-Sánchez AM; Burroughs CL; Cavaliere S; Barton SJ; Chen S; Yang XW; Rebec GV
J Neurosci; 2015 Mar; 35(10):4440-51. PubMed ID: 25762686
[TBL] [Abstract][Full Text] [Related]
3. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
4. Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease.
Schmidt ME; Buren C; Mackay JP; Cheung D; Dal Cengio L; Raymond LA; Hayden MR
BMC Biol; 2018 Jun; 16(1):58. PubMed ID: 29945611
[TBL] [Abstract][Full Text] [Related]
5. Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load.
Milnerwood AJ; Raymond LA
J Physiol; 2007 Dec; 585(Pt 3):817-31. PubMed ID: 17947312
[TBL] [Abstract][Full Text] [Related]
6. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
Laforet GA; Sapp E; Chase K; McIntyre C; Boyce FM; Campbell M; Cadigan BA; Warzecki L; Tagle DA; Reddy PH; Cepeda C; Calvert CR; Jokel ES; Klapstein GJ; Ariano MA; Levine MS; DiFiglia M; Aronin N
J Neurosci; 2001 Dec; 21(23):9112-23. PubMed ID: 11717344
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
[TBL] [Abstract][Full Text] [Related]
8. Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.
Creus-Muncunill J; Ehrlich ME
Neurotherapeutics; 2019 Oct; 16(4):957-978. PubMed ID: 31529216
[TBL] [Abstract][Full Text] [Related]
9. Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse.
Brown TB; Bogush AI; Ehrlich ME
Hum Mol Genet; 2008 Oct; 17(20):3095-104. PubMed ID: 18632688
[TBL] [Abstract][Full Text] [Related]
10. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
[TBL] [Abstract][Full Text] [Related]
11. Functional interactions within striatal microcircuit in animal models of Huntington's disease.
Ghiglieri V; Bagetta V; Calabresi P; Picconi B
Neuroscience; 2012 Jun; 211():165-84. PubMed ID: 21756979
[TBL] [Abstract][Full Text] [Related]
12. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
Spires TL; Grote HE; Garry S; Cordery PM; Van Dellen A; Blakemore C; Hannan AJ
Eur J Neurosci; 2004 May; 19(10):2799-807. PubMed ID: 15147313
[TBL] [Abstract][Full Text] [Related]
13. Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease.
Indersmitten T; Tran CH; Cepeda C; Levine MS
J Neurophysiol; 2015 Apr; 113(7):2953-66. PubMed ID: 25673747
[TBL] [Abstract][Full Text] [Related]
14. Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease.
Buren C; Parsons MP; Smith-Dijak A; Raymond LA
Neurobiol Dis; 2016 Mar; 87():80-90. PubMed ID: 26711622
[TBL] [Abstract][Full Text] [Related]
15. Altered mitochondrial Ca
Yoo H; Park H
Biochem Biophys Res Commun; 2024 Jul; 716():150010. PubMed ID: 38704892
[TBL] [Abstract][Full Text] [Related]
16. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
Raymond LA; André VM; Cepeda C; Gladding CM; Milnerwood AJ; Levine MS
Neuroscience; 2011 Dec; 198():252-73. PubMed ID: 21907762
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional features of medium spiny neurons in the BACHDΔN17 mouse model of Huntington's Disease.
Goodliffe J; Rubakovic A; Chang W; Pathak D; Luebke J
PLoS One; 2020; 15(6):e0234394. PubMed ID: 32574176
[TBL] [Abstract][Full Text] [Related]
19. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
[TBL] [Abstract][Full Text] [Related]
20. Huntington aggregates may not predict neuronal death in Huntington's disease.
Kuemmerle S; Gutekunst CA; Klein AM; Li XJ; Li SH; Beal MF; Hersch SM; Ferrante RJ
Ann Neurol; 1999 Dec; 46(6):842-9. PubMed ID: 10589536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
